Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Poortmans, P.M.

Search results

  • RSS Feed
(1 - 7 of 7)
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
Alberro, J.A.; Ballester, B.; Deulofeu, P.; Fabregas, R.; Fraile, M.; Gubern, J.M.; ... ; Mihura, J 2018
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
Article / Letter to editor
open access
Cause-specific mortality among patients with Hodgkin lymphoma (HL) up to 40 years after treatment
Schaapveld, M.; Eggermond, A.M. van; Janus, C.P.M.; Krol, A.D.G.; Raemaekers, J.M.M.; Clevers-Petersen, E.J.; ... ; Leeuwen, F.E. van 2014
Cause-specific mortality among patients with Hodgkin lymphoma (HL) up to 40 years after treatment
Article / Letter to editor
metadata only
Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis-an EORTC STBSG and ROG study (EORTC 62991-22998)
Keus, R.B.; Nout, R.A.; Blay, J.Y.; Jong, J.M. de; Hennig, I.; Saran, F.; ... ; Graaf, W.T.A. van der 2013
Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis-an EORTC STBSG and ROG study (EORTC 62991-22998)
Article / Letter to editor
open access
Second Cancer Risk 40 Years After Hodgkin Lymphoma Treatment
Aleman, B.; Schaapveld, M.; Eggermond, A.M. van; Janus, C.P.; Krol, A.D.; Maazen, R.W. van der; ... ; Leeuwen, F.E. van 2012
Second Cancer Risk 40 Years After Hodgkin Lymphoma Treatment
Article / Letter to editor
metadata only
Long-term cosmetic changes after breast-conserving treatment of patients with stage I-II breast cancer and included in the EORTC 'boost versus no boost' trial
Immink, J.M.; Putter, H.; Bartelink, H.; Cardoso, J.S.; Cardoso, M.J.; Hulst-Vijgen, M.H.V. van der; ... ; Struikmans, H. 2012
Long-term cosmetic changes after breast-conserving treatment of patients with stage I-II breast cancer and included in the EORTC 'boost versus no boost' trial
Article / Letter to editor
metadata only
Second cancer risk 40 years after cure for Hodgkin lymphoma
Schaapveld, M.; Aleman, B.M.; Eggermond, A.M.; Janus, C.P.; Krol, A.; Maazen, R.W.M. van der; ... ; Leeuwen, F.E. van 2012
Second cancer risk 40 years after cure for Hodgkin lymphoma
Article / Letter to editor
metadata only
An increased utilisation rate and better compliance to guidelines for primary radiotherapy for breast cancer 1997 till 2008: a population-based study in the Netherlands
Struikmans, H.; Aarts, M.J.; Jobsen, J.J.; Koning, C.C.E.; Merkus, J.W.S.; Lybeert, M.L.; ... ; Coebergh, J.W.W. 2011
An increased utilisation rate and better compliance to guidelines for primary radiotherapy for breast cancer 1997 till 2008: a population-based study in the Netherlands
Article / Letter to editor
metadata only